Evidence map›Paper›PMID 36676054›Full record

ArticleLife (Basel, Switzerland)2022

Detection of Recombinant Proteins SOX2 and OCT4 Interacting in HEK293T Cells Using Real-Time Quantitative PCR.

Darkhan Kanayev, Diana Abilmazhenova, Ilyas Akhmetollayev, Aliya Sekenova, Vyacheslav Ogay, Arman Kulyyassov

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Darkhan KanayevLimited Liability Partnership "National Center for Biotechnology" Ministry of Healthcare of the Republic of Kazakhstan, 3/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan.
Diana AbilmazhenovaLimited Liability Partnership "National Center for Biotechnology" Ministry of Healthcare of the Republic of Kazakhstan, 3/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan.
Ilyas AkhmetollayevLimited Liability Partnership "National Center for Biotechnology" Ministry of Healthcare of the Republic of Kazakhstan, 3/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan.
Aliya SekenovaLimited Liability Partnership "National Center for Biotechnology" Ministry of Healthcare of the Republic of Kazakhstan, 3/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan.
Vyacheslav OgayLimited Liability Partnership "National Center for Biotechnology" Ministry of Healthcare of the Republic of Kazakhstan, 3/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan.ORCID 0000-0001-5029-5255
Arman KulyyassovLimited Liability Partnership "National Center for Biotechnology" Ministry of Healthcare of the Republic of Kazakhstan, 3/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan.ORCID 0000-0002-7932-5689
National Center for Biotechnology · KZ

Funding

Ministry of education and science of Republic of Kazakhstan AP09259838
6 · The paper itself

Abstract

In vivo biotinylation using wild-type and mutants of biotin ligases is now widely applied for the study of cellular proteomes. The commercial availability of kits for the highly efficient purification of biotinylated proteins and their excellent compatibility with LC-MS/MS protocols are the main reasons for the choice of biotin ligases. Since they are all enzymes, however, just a very low expression in cells is required for experiments. Therefore, it can be difficult to perform the quantifications of these enzymes in various samples. Traditional methods, such as western blotting, are not always fit for the detection of the expression levels. Therefore, real-time qRT-PCR, a technology that is more sensitive, was used in this study to quantify the expression of BirA fusions. Using this method, we detected high expression levels of BirA fusions in models of interactions of pluripotency transcription factors to carry out their relative quantification. We also found the absence of the competing endogenous proteins SOX2 and OCT4, as well as no cross-reactivity between BAP/BirA and the endogenous biotinylation system in HEK293T cells. Thus, these data indicated that the high level of biotinylation is due to the in vivo interaction of BAP-X and BirA-Y (X,Y = SOX2, OCT4) in the cell rather than their random collision, a big difference in the expression level of BirA fusions across samples or endogenous biotinylation.

Indexed as

Biotin Acceptor Peptide (BAP)biotin ligasesliquid chromatography tandem mass-spectrometry (LC-MS/MS)Proximity Utilizing Biotinylation (PUB)reverse transcription polymerase chain reaction (RT-PCR)transcription factors of pluripotencywestern blotting

Identifiers

PMID36676054
PMCPMC9862934
OpenAlexW4313440041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.